Platelet-rich Plasma Therapy for Hair Loss
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effectiveness of platelet-rich plasma (PRP) therapy for treating hair loss, specifically male pattern hair loss in females. PRP, derived from a person's own blood, aids in hair regrowth. Participants will receive PRP on one side of their scalp and a placebo (a harmless solution) on the other to compare results. Women diagnosed with androgenic alopecia who are not currently on any hair loss treatments might be suitable for this study. As an Early Phase 1 trial, this research aims to understand how PRP therapy works in people, offering participants the chance to be among the first to explore this innovative treatment.
Will I have to stop taking my current medications?
If you are currently taking medication for alopecia (hair loss), you will need to stop and have a 2-week period without it before joining the trial. If you are on anticoagulant therapy, you cannot participate in the trial.
Is there any evidence suggesting that platelet-rich plasma therapy is likely to be safe for humans?
Research has shown that platelet-rich plasma (PRP) therapy is generally safe for treating hair loss. In one study, patients reported no side effects after receiving PRP injections. Another study found that PRP positively affected male pattern hair loss and noted no major side effects. Overall, moderate evidence supports PRP's safety and effectiveness in increasing hair thickness and reducing hair loss. Because PRP is made from the patient's own blood, it is usually well-tolerated with a low risk of negative reactions.12345
Why do researchers think this study treatment might be promising?
Platelet-rich plasma (PRP) therapy is unique because it uses components from your own blood to potentially stimulate hair growth, which is different from standard treatments like minoxidil or finasteride. These traditional options often focus on hormonal pathways or topical solutions, but PRP directly injects concentrated platelets into the scalp, which may promote healing and hair follicle stimulation. Researchers are excited because PRP could offer a natural, targeted approach with fewer side effects, potentially leading to effective hair restoration in a more personalized manner.
What evidence suggests that platelet-rich plasma therapy might be an effective treatment for hair loss?
Studies have shown that platelet-rich plasma (PRP) therapy can improve hair growth and thickness in individuals with androgenic alopecia, commonly known as male pattern hair loss. Research indicates that PRP injections increase hair density more effectively than standard treatments. Other findings suggest that PRP not only promotes new hair growth but also prevents further hair loss. These results are promising for both men and women experiencing this type of hair loss. In this trial, participants will receive PRP on one side of the scalp and a placebo (saline solution) on the other, allowing for a direct comparison of PRP's effectiveness. Overall, PRP therapy is gaining attention for its potential to treat hair loss effectively.24678
Who Is on the Research Team?
Rita Pichardo, MD
Principal Investigator
Wake Forest University School of Medicine, Department of Dermatology
Are You a Good Fit for This Trial?
This trial is for women over 18 with androgenic alopecia who aren't currently treating their hair loss or have stopped treatments for at least two weeks. Participants must be able to follow the study's procedures and give written consent. Women can't join if they're pregnant, breastfeeding, have anemia, are on blood thinners, have certain skin conditions like psoriasis, infections or metastatic diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive PRP therapy once monthly for 3 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Platelet-rich Plasma
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor